Filings under AARD by Across America Real Estate Corp (CIK 0001233275) from Dec 29, 2005 to Aug 17, 2007 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Sun Nelson | See Remarks | Sell(S) | 62K | $5.18 | $321K |
| Sep 10, 2026 | Sun Nelson | See Remarks | Sell(S) | 15K | $5.00 | $74K |
| Aug 14, 2026 | Tong Victor Edward Jr | Director | Grant(A) | 45K | — | $0 |
| Aug 14, 2026 | Baynes Roy D. | Director | Grant(A) | 45K | — | $0 |
| Aug 14, 2026 | Graf Susan E | Director | Grant(A) | 45K | — | $0 |
| Aug 14, 2026 | Chi Jeffrey | Director | Grant(A) | 45K | — | $0 |
| Feb 9, 2026 | Jaiman Manasi | Chief Medical Officer | Grant(A) | 71K | — | $0 |
| Feb 9, 2026 | Lee Tien-Li | Chief Executive Officer, Director, 10% Owner | Grant(A) | 204K | — | $0 |
| Feb 9, 2026 | Sun Nelson | Chief Financial Officer | Grant(A) | 71K | — | $0 |
| Dec 11, 2025 | Lee Tien-Li | Chief Executive Officer, Director, 10% Owner | Buy(P) | 7K | $14.49 | $101K |
| Dec 11, 2025 | Sun Nelson | Chief Financial Officer | Buy(P) | 3K | $14.40 | $43K |
| Oct 15, 2025 | Jones Bryan | Chief Operating Officer | Option exercise(M) | 1K | $4.24 | $5K |
| Oct 15, 2025 | Jones Bryan | Chief Operating Officer | Option exercise(M) | 1K | — | $0 |
| Oct 15, 2025 | Lee Tien-Li | Chief Executive Officer, Director, 10% Owner | Option exercise(M) | 1K | $4.24 | $5K |
| Oct 15, 2025 | Lee Tien-Li | Chief Executive Officer, Director, 10% Owner | Option exercise(M) | 1K | — | $0 |
| Sep 15, 2025 | Lee Tien-Li | Chief Executive Officer, Director, 10% Owner | Buy(P) | 7K | $9.51 | $62K |
| Sep 15, 2025 | Lee Tien-Li | Chief Executive Officer, Director, 10% Owner | Buy(P) | 4K | $9.94 | $35K |
| Sep 12, 2025 | Lee Tien-Li | Chief Executive Officer, Director, 10% Owner | Buy(P) | 5K | $8.50 | $43K |
| Sep 11, 2025 | Lee Tien-Li | Chief Executive Officer, Director, 10% Owner | Buy(P) | 6K | $7.82 | $47K |
| Sep 10, 2025 | Lee Tien-Li | Chief Executive Officer, Director, 10% Owner | Buy(P) | 9K | $7.91 | $71K |
| Sep 9, 2025 | Sun Nelson | Chief Financial Officer | Buy(P) | 6K | $8.07 | $48K |
| Aug 28, 2025 | Lee Tien-Li | Chief Executive Officer, Director, 10% Owner | Option exercise(M) | 17K | $4.24 | $73K |
| Aug 28, 2025 | Lee Tien-Li | Chief Executive Officer, Director, 10% Owner | Option exercise(M) | 17K | — | $0 |
| Jun 11, 2025 | Graf Susan E | Director | Grant(A) | 31K | — | $0 |
| Jun 11, 2025 | Jones Bryan | Chief Operating Officer | Grant(A) | 122K | — | $0 |
| Jun 11, 2025 | Tong Victor Edward Jr | Director | Grant(A) | 61K | — | $0 |
| Jun 11, 2025 | Baynes Roy D. | Director | Grant(A) | 31K | — | $0 |
| Jun 11, 2025 | Sun Nelson | Chief Financial Officer | Grant(A) | 210K | — | $0 |
| Jun 11, 2025 | Jaiman Manasi | Chief Medical Officer | Grant(A) | 127K | — | $0 |
| Jun 11, 2025 | Chi Jeffrey | Director | Grant(A) | 61K | — | $0 |
| Jun 11, 2025 | Lee Tien-Li | Chief Executive Officer, Director, 10% Owner | Grant(A) | 550K | — | $0 |
| Feb 14, 2025 | Chen Bihua | Insider | Buy(P) | 188K | $16.00 | $3.0M |
| Feb 14, 2025 | Chen Bihua | Insider | Conversion(C) | 800K | — | — |
| Feb 14, 2025 | Chen Bihua | Insider | Conversion(C) | 6.8M | — | — |
| Feb 14, 2025 | Sun Nelson | Chief Financial Officer | Buy(P) | 10K | $16.00 | $160K |
| Feb 14, 2025 | Sun Nelson | Chief Financial Officer | Conversion(C) | 7K | — | — |
| Feb 14, 2025 | Sun Nelson | Chief Financial Officer | Conversion(C) | 59K | — | $0 |
| Feb 14, 2025 | Lee Tien-Li | Chief Executive Officer, Director, 10% Owner | Buy(P) | 17K | $16.00 | $265K |
| Feb 14, 2025 | Lee Tien-Li | Chief Executive Officer, Director, 10% Owner | Conversion(C) | 41K | — | — |
| Feb 14, 2025 | Lee Tien-Li | Chief Executive Officer, Director, 10% Owner | Conversion(C) | 350K | — | $0 |
| Feb 14, 2025 | Vickers Venture Fund VI Pte Ltd | 10% Owner | Conversion(C) | 1.6M | — | — |
| Feb 14, 2025 | Vickers Venture Fund VI Pte Ltd | 10% Owner | Conversion(C) | 413K | — | — |
| Feb 14, 2025 | Vickers Venture Fund VI Pte Ltd | 10% Owner | Conversion(C) | 13.9M | — | $0 |
| Feb 14, 2025 | Vickers Venture Fund VI Pte Ltd | 10% Owner | Conversion(C) | 3.5M | — | $0 |
| Feb 14, 2025 | Chi Jeffrey | Director | Conversion(C) | 133K | — | — |
| Feb 14, 2025 | Chi Jeffrey | Director | Conversion(C) | 1.1M | — | $0 |
| Feb 14, 2025 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | Conversion(C) | 2.3M | — | — |
| Feb 14, 2025 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | Buy(P) | 625K | $16.00 | $10.0M |
| Feb 14, 2025 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | Buy(P) | 625K | $16.00 | $10.0M |
| Feb 14, 2025 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | Conversion(C) | 333K | — | — |
| Feb 14, 2025 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | Conversion(C) | 19.8M | — | $0 |
| Feb 14, 2025 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | Conversion(C) | 2.8M | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Aardvark Therapeutics, Inc., SEC CIK 0001774857. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under AARD and shows every filing by that issuer. Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for AARD